GBT
VRTX icon

Grove Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Grove Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.02M Sell
1,948
-577
-23% -$295K 0.1% 114
2026
Q2 		$1.25M Sell
2,525
-122
-5% -$54.1K 0.12% 102
2026
Q1 		$1.18M Buy
2,647
+563
+27% +$263K 0.13% 99
2025
Q4 		$945K Buy
2,084
+1,645
+375% +$709K 0.11% 124
2025
Q3 		$172K Sell
439
-26
-6% -$10.9K 0.02% 264
2025
Q2 		$207K Sell
465
-15
-3% -$6.91K 0.03% 244
2025
Q1 		$233K Buy
480
+7
+1% +$3.26K 0.03% 222
2024
Q4 		$190K Buy
473
+63
+15% +$29.2K 0.03% 224
2024
Q3 		$191K Buy
410
+22
+6% +$10.6K 0.03% 227
2024
Q2 		$182K Sell
388
-14
-3% -$6.08K 0.03% 229
2024
Q1 		$168K Hold
402
– – 0.03% 245
2023
Q4 		$164K Sell
402
-4
-1% -$1.48K 0.03% 236
2023
Q3 		$141K Sell
406
-132
-25% -$46.2K 0.03% 244
2023
Q2 		$189K Sell
538
-12
-2% -$4.04K 0.04% 219
2023
Q1 		$173K Buy
550
+32
+6% +$9.6K 0.04% 226
2022
Q4 		$150K Buy
+518
New +$158K 0.03% 237
2018
Q1 		– Sell
-55
Closed -$8K – 451
2017
Q4 		$8K Sell
55
-65
-54% -$9.62K ﹤0.01% 458
2017
Q3 		$18K Hold
120
– – 0.01% 410
2017
Q2 		$15K Buy
120
+65
+118% +$7.82K 0.01% 412
2017
Q1 		$6K Hold
55
– – ﹤0.01% 406
2016
Q4 		$4K Buy
+55
New +$4.47K ﹤0.01% 498

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Grove Bank & Trust's VRTX Position: Q3 2026 in Review

Grove Bank & Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 23% in Q3 2026, selling an estimated $295K and leaving 1,948 shares worth $1.02M. The position accounts for 0.1% of the portfolio, ranked #114.

Grove Bank & Trust first reported a position in VRTX in Q4 2016 and has held it in 21 quarters since. The position peaked at $1.25M in Q2 2026. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Grove Bank & Trust held 1,948 shares of Vertex Pharmaceuticals worth $1.02M as of Q3 2026.
  • Grove Bank & Trust sold 577 Vertex Pharmaceuticals shares in Q3 2026, an estimated $295K.
  • Vertex Pharmaceuticals made up 0.1% of Grove Bank & Trust's portfolio in Q3 2026, its #114 holding.
  • Grove Bank & Trust first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 21 quarters since.
  • Grove Bank & Trust's Vertex Pharmaceuticals position peaked at $1.25M in Q2 2026.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.